JBIO
Jade Biosciences
JBIO
JBIO
80 hedge funds and large institutions have $45.1M invested in Jade Biosciences in 2024 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 28 increasing their positions, 10 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.22% less ownership
Funds ownership: 2.92% → 2.69% (-0.22%)
95% less capital invested
Capital invested by funds: $841M → $45.1M (-$796M)
100% less funds holding in top 10
Funds holding in top 10: 6 → 0 (-6)
Holders
80
Holding in Top 10
–
Calls
$516K
Puts
$275K
Top Buyers
| 1 | +$2.34M | |
| 2 | +$1.54M | |
| 3 | +$1.34M | |
| 4 |
Millennium Management
New York
|
+$962K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$730K |
Top Sellers
| 1 | -$35.6M | |
| 2 | -$31.6M | |
| 3 | -$26.2M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$23.5M |
| 5 |
O
OrbiMed
New York
|
-$16.7M |